Mr. Peter Barron:

There is a bit of confusion here and I hope I did not cause it. The part of my opening remarks to which Deputy Ó Caoláin referred related to the transparency directive which is the directive that deals with the terms under which medical products are covered by health insurance systems. On the second page of my presentation, I stated that the Department had concerns about the original Commission proposal but the Commission proposal, to which I am referring, is the transparency directive rather than the medical device directives. I apologise if I caused confusion over that.